Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T15:40:40.961Z.
Calculation as of: 2026-10-06T15:40:40.961Z.
Quote observation: 2026-10-06T15:35:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c9508078213b28dfeff6809371853141f28b2786ea2d18fc4f82dd6840af9a4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Advanced Biomed Inc. Common Stock
Market Cap
$9.21M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.15M
EV/Sales Ratio
1.28x
TTM Avg
50.25x
3Y Avg
49.01x
5Y Avg
49.01x
Market Cap
$9.80M
EV/Sales Ratio
1631.29x
TTM Avg
683.01x
3Y Avg
535.46x
5Y Avg
1037.99x
Market Cap
$8.53M
EV/Sales Ratio
0.76x
TTM Avg
0.33x
3Y Avg
0.31x
5Y Avg
0.34x
Market Cap
$10.08M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.01M
EV/Sales Ratio
0.80x
TTM Avg
3.06x
3Y Avg
5.84x
5Y Avg
28.58x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $9.21M | N/A | N/A | N/A | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.15M | 1.28x | 50.25x | 49.01x | 49.01x |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.29M | N/A | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.68M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.80M | 1631.29x | 683.01x | 535.46x | 1037.99x |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | 0.76x | 0.33x | 0.31x | 0.34x |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.08M | N/A | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.37M | 4.80x | 2.16x | 2.16x | 2.16x |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | 0.80x | 3.06x | 5.84x | 28.58x |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | N/A | 4.01x | 4.01x | 4.01x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
